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Allergy is mediated by Th2 cells
The incidence of allergic diseases is cur-
rently  on  the  rise.  In western  societies, 
up  to 25% of  children are  sensitized  to 
allergens  such  as  the  house  dust mite 
(HDM), pollen,  animal dander, or  food 
components. This  sensitization  is  indi-
cated  clinically  by  the  presence  in  the 
serum of allergen-specific IgE and by an 
immediate wheal and flare reaction after 
skin prick  testing with  these  allergens. 
In most, but not all, sensitized individu-
als, natural allergen exposure via food or 






















The complement system in asthma
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Figure 1
Immune regulation by DC subsets and the 
influence of complement. (A) Under condi-
tions of immune tolerance to inhaled antigens, 
pDCs outnumber mDCs. pDCs suppress the 
generation of effector cells by mDCs by send-
ing an unknown inhibitory signal to mDCs and 
to T cells (in the form of programmed death 
ligand-1 [PDL-1] or high level indoleamine 
dioxygenase [2,3-IDO] activity). The T cell 
division that occurs in response to partially 
mature mDCs is abortive (i.e., it does not lead 
to generation of effector cells) and leads to 
generation of Tregs. ICOSL, inducible costim-
ulator ligand. (B) Under conditions that lead 
to sensitization to inhaled antigens, mature 
mDCs greatly outnumber pDCs, thus releas-
ing the inhibitory “brake” on T cell stimulation. 
It is also possible that pDCs become directly 
stimulatory, subsequently inducing rather 
than suppressing T cell responses. In this 
issue of the JCI, Köhl et al. (15) show that, 
under conditions of C5aR blockade or lack of 
C5 generation, there is a major increase in 
the number of mDCs compared with pDCs, 
leading to Th2 sensitization. mDCs also pro-
duce the Th2-selective chemokines CCL17 
and CCL22, further intensifying Th2 effec-
tor cytokine production. This might explain 
why C5-deficient mice are more susceptible 
to asthma. Exactly how complement is acti-
vated in response to allergen inhalation is still 
unknown, but could involve exposure to pro-
teolytic allergens, production of endotoxin by 
microbes, or baseline activation in the lungs. 
If microbial factors induce C5a in the lungs, 
the absence of these might also explain an 
increase in sensitization with increased clean-
liness (hygiene hypothesis).
ics and mice with experimentally induced 
asthma,  compared with  controls  (7–9). 



































of  systemic  adjuvant,  tolerance was  the 
outcome (16–18), but when the C5aR was 
blocked, Th2 sensitization occurred and 



















Th2-type allergic sensitization  











































































(3,  32).  Immature  or  partially mature 
mDCs  expressing  inducible  costimula-
tor ligand induce abortive T cell prolif-

































Complement C5aR controls  
DC function in the airways
In the article by Köhl et al. in this issue 
(15), it is again shown that lung mDCs are 
the predominant cell  type  that  induces 
effector  cytokine  production  by  CD4+ 
T cells, whereas pDCs do not stimulate 




led  to  development  of  an  effector Th2 








When  C5aR  was  blocked,  the  relative 
increase  in  the  number  of  mDCs  was 
even higher, approaching 100 mDCs to 1 
pDC. Under these conditions of low pDC 

































	 The	Journal	of	Clinical	Investigation      http://www.jci.org      Volume 116      Number 3      March 2006  631
known  ligands  for  CCR4.  In  this  way, 



















Prospects for the future
The Köhl  et  al.  study  (15)  raises many 
questions  for  future  research.  It  illus-
trates how the fine-tuning of DC func-
tion  by  signals  from  the  allergen  and 
the  innate  immune  response  is  crucial 
to understanding the process of allergic 
sensitization  (Figure 1).  In  this  regard, 
it will be paramount to understand how 










ficient  strain  of  C3H/HeJ mice,  Tregs 
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fluid  after  segmental  allergen  provocation  in 























anaphylatoxin  in  type  2  immunity  in  asthma. 
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Good news in the nuclear envelope:  
loss of lamin A might be a gain
Paola Scaffidi and Tom Misteli

















































































life  span,  bone  structure,  and muscle 
functionality, LmnaLCO/LCO mice appeared 
indistinguishable  from wild-type mice, 
and histopathological  analysis did not 
reveal any tissue abnormality. This is in 
Nonstandard	abbreviations	used: FTI, farnesyltrans-
ferase inhibitor; HGPS, Hutchinson-Gilford progeria 
syndrome.
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